Modulation of chromosome function by chromatin remodeling agents
CA 2409408 A1 · Owner: Universite De Geneve · Inventors: Laemmli, Ulrich
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention concerns a process for modulating the function of a DNA element in a eukaryotic cell, comprising the step of contacting a genomic DNA element, so-called "chromatin responsive element" (CRE) with a compound , having a molecular weight of less than approximately 5 KDa and having the , capacity to bind a sequence-specific manner to said CRE said step of , contacting being carried out in conditions permitting chromatin remodeling of the CRE by said compound, wherein said chromatin remodeling of the CRE alters the activity of one or more other DNA elements so called "modulated DNA , elements" in the genome.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed June 26, 2001. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 26, 2021.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 26, 2023.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.